Status:

UNKNOWN

Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent

Lead Sponsor:

Maasstad Hospital

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This is a prospective, randomized, multi center study. Approximately 2700 patients will be entered in the study and will be randomized on a 2:1 basis. Patients who meet the eligibility criteria will b...

Detailed Description

The main objective of the study is a head to head comparison of the everolimus eluting XIENCE-V ®, XIENCE-Prime® or PROMUS ® stent with the biolimus A9 eluting NOBORI® stent in order to observe whethe...

Eligibility Criteria

Inclusion

  • The patient is at least 18 years old and has a life expectancy of 5 years.
  • Patient undergoes a PCI procedure for indications according to the Dutch and European guidelines
  • Patient is willing to comply with the extended follow-up period of 2 to 5 years(for secondary endpoint only)
  • Reference lumen diameter of the treated vessels between 2.0 - 4.0 mm.
  • Informed consent

Exclusion

  • Expected non-adherence to dual antiplatelet therapy for 1 year (e.g: known allergy to ASA or thienopyridines like clopidogrel)
  • Expected major surgery within 30 days (these patients will receive bare metal stents)
  • Cardiogenic shock (Kilip class 4)
  • Previous PCI procedures with implantation of drug eluting stents within 1 year.
  • Expected loss for follow up
  • Enrollment in an investigative stent study with different stents
  • Inability to implant Nobori or Xience-V / Promus stent(s)

Key Trial Info

Start Date :

January 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2015

Estimated Enrollment :

2700 Patients enrolled

Trial Details

Trial ID

NCT01233453

Start Date

January 1 2009

End Date

December 1 2015

Last Update

January 30 2014

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

Onassis cardiac Surgery Centre

Athens, Greece

2

Onze Lieve Vrouwe Gasthuis

Amsterdam, Netherlands

3

Amphia Ziekenhuis

Breda, Netherlands

4

Medisch Centrum Leeuwarden

Leeuwarden, Netherlands